Catalyst Pharmaceuticals Financials

Values in thousands	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Revenue	$146,563	$141,421	$141,820	$128,695
Gross Profit	116,605	123,510	120,177	109,418
EBITDA	78,753	72,827	72,301	50,909
EBIT	69,293	63,367	62,772
Net Income	52,108	56,737	55,936	43,884
Net Change In Cash	146,563	141,421	141,820	128,695
Free Cash Flow	71,272	60,043	70,789	72,612
Cash	652,800	580,656	517,553	442,331
Basic Shares	127,543	126,958	126,280	125,407

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$491,734	$398,204	$214,203	$140,833
Gross Profit	422,889	313,672	179,810	118,949
EBITDA	232,898	119,693	103,077	52,577
EBIT	195,124	86,812	101,838	52,385
Net Income	163,889	71,410	83,079	39,482
Net Change In Cash	491,734	398,204	214,203	140,833
Cost of Revenue			126,950	41,208
Free Cash Flow	239,252	-54,924	116,018	59,351
Cash	517,553	137,636	298,395	171,445
Basic Shares	124,944	113,753	111,375	107,795